Accéder au contenu
Merck
Toutes les photos(1)

Documents

1045009

USP

Atropine sulfate

United States Pharmacopeia (USP) Reference Standard

Synonyme(s) :

Atropine sulfate salt monohydrate, α-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, Tropine tropate

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule linéaire :
(C17H23NO3)2 · H2SO4 · H2O
Numéro CAS:
5908-99-6
Poids moléculaire :
694.83
Numéro Beilstein :
6109275
Numéro MDL:
MFCD00074815
Code UNSPSC :
41116107
ID de substance PubChem :
329749082
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

atropine

Fabricant/nom de marque

USP

Pf

189-192 °C (A) (lit.)

Application(s)

pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

Chaîne SMILES 

O.OS(O)(=O)=O.CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)c3ccccc3.CN4[C@H]5CC[C@@H]4C[C@@H](C5)OC(=O)C(CO)c6ccccc6

InChI

1S/2C17H23NO3.H2O4S.H2O/c2*1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12;1-5(2,3)4;/h2*2-6,13-16,19H,7-11H2,1H3;(H2,1,2,3,4);1H2/t2*13-,14+,15+,16?;;

Clé InChI

JPKKQJKQTPNWTR-CHYDPLAESA-N

Informations sur le gène

human ... CHRM1(1128) , CHRM2(1129) , CHRM3(1131)

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Atropine sulfate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Atropine Sulfate Injection
  • Atropine Sulfate Ophthalmic Solution
  • Atropine Sulfate Ophthalmic Ointment
  • Diphenoxylate Hydrochloride and Atropine Sulfate Tablets
  • Diphenoxylate Hydrochloride and Atropine Sulfate Oral Solution
  • Atropine

Actions biochimiques/physiologiques

Competitive nonselective antagonist at central and peripheral muscarinic acetylcholine receptors.

Remarque sur l'analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

A1400000

Atropine sulfate, European Pharmacopoeia (EP) Reference Standard

M1300000

Methylatropine bromide, European Pharmacopoeia (EP) Reference Standard

Y0000845

Atropine for peak identification, European Pharmacopoeia (EP) Reference Standard

Y0000816

Atropine impurity B, European Pharmacopoeia (EP) Reference Standard

Y0000878

Atropine, European Pharmacopoeia (EP) Reference Standard

BP023

Atropine sulfate, British Pharmacopoeia (BP) Reference Standard

BP036

Benzatropine mesilate, British Pharmacopoeia (BP) Reference Standard

1044990

Atropine, United States Pharmacopeia (USP) Reference Standard

BP689

Desmethyl benzatropine hydrochloride, British Pharmacopoeia (BP) Reference Standard

Pictogrammes

Skull and crossbones
GHS06

Mention d'avertissement

Danger

Mentions de danger

H300 + H330

Classification des risques

Acute Tox. 2 Inhalation - Acute Tox. 2 Oral

Code de la classe de stockage

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

Classe de danger pour l'eau (WGK)

WGK 3

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 6

1 of 6

Scopolamine hydrobromide United States Pharmacopeia (USP) Reference Standard

USP

1610001

Scopolamine hydrobromide

Cromolyn sodium United States Pharmacopeia (USP) Reference Standard

USP

1150502

Cromolyn sodium

Scopolamine Hydrobromide Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1470

Scopolamine Hydrobromide

Diclofenac sodium United States Pharmacopeia (USP) Reference Standard

USP

1188800

Diclofenac sodium

Carbachol European Pharmacopoeia (EP) Reference Standard

Y0000113

Carbachol

Carbamoylcholine chloride ≥98% (titration), crystalline

Sigma-Aldrich

C4382

Carbamoylcholine chloride

Miklós Palotai et al.
Neurochemical research, 39(8), 1477-1483 (2014-06-05)
The nociceptin/orphanin FQ peptide (NOP) receptor and its endogenous ligand plays role in several physiologic functions of the central nervous system, including pain, locomotion, anxiety and depression, reward and drug addiction, learning and memory. Previous studies demonstrated that the NOP-receptor
Cristina Cuesta et al.
Vascular pharmacology, 63(1), 4-12 (2014-09-03)
The role of calcitonin gene-related peptide (CGRP) in the modulation of vascular tone has been widely documented. Indeed, electrical stimulation of the perivascular sensory outflow in pithed rats induces vasodepressor responses by activation of CGRP receptors. This study investigated the
A I Jobling et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 29(2), 696-710 (2014-11-14)
Age-related macular degeneration (AMD) is a leading cause of vision loss, characterized by drusen deposits and thickened Bruch's membrane (BM). This study details the capacity of nanosecond laser treatment to reduce drusen and thin BM while maintaining retinal structure. Fifty
Claude Botha et al.
Gut, 64(4), 611-617 (2014-05-30)
Autonomic nervous system dysfunction has been implicated in visceral hypersensitivity. However, the specific contribution of the parasympathetic nervous system (PNS) is unclear. We aimed to determine whether physiological and pharmacological manipulation of parasympathetic tone influences the development of hypersensitivity in
Francois Malecaze et al.
Investigative ophthalmology & visual science, 55(10), 6712-6721 (2014-09-25)
To characterize the expression of the bone morphogenetic protein-1 (BMP-1)/tolloid-like proteinases (collectively called BTPs), which include BMP-1, mammalian tolloid (mTLD), and mammalian tolloid-like 1 (mTLL-1) and 2 (mTLL-2), as well as the associated proteins procollagen C-proteinase enhancers (PCPE-1 and -2)
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique